Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 18/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.46 |
| ▸ | AURKA | O14965 | 1/20 | 0.45 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29016163 | 1.00 | RET (0.61) | RETKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL30453270 | 0.89 | RET (0.61) | RETJAK2AURKAAURKB | |
| SCHEMBL30452755 | 0.86 | RET (0.56) | RETJAK2FLT3 | |
| SCHEMBL28429868 | 0.86 | RET (0.56) | RETJAK2FLT3 | |
| Hydrochloric Acid SCHEMBL30453172 | 0.81 | RET (0.59) | RETJAK2FLT3 | |
| Hydrochloric Acid SCHEMBL28434225 | 0.81 | RET (0.59) | RETJAK2FLT3 | |
| SCHEMBL22041676 | 0.81 | RET (0.55) | RETALDH1A1JAK2FLT3 | |
| SCHEMBL19796299 | 0.80 | RET (0.73) | RET | |
| SCHEMBL22041785 | 0.80 | RET (0.55) | RETJAK2FLT3 | |
| SCHEMBL21744951 | 0.79 | RET (0.60) | RETJAK2AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111484479-B | Azacyclic compounds, pharmaceutical compositions containing the same, and methods of making and using the same | 四川科伦博泰生物医药股份有限公司 | 2023-06-13 | — | — | CN | disclosed |